Detailed information for compound 282677

Basic information

Technical information
  • TDR Targets ID: 282677
  • Name: methyl 2-[(7-chloro-2-oxo-3-phenyl-1H-quinoli n-4-yl)oxy]acetate
  • MW: 343.761 | Formula: C18H14ClNO4
  • H donors: 1 H acceptors: 3 LogP: 4.31 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: COC(=O)COc1c(c2ccccc2)c(O)nc2c1ccc(c2)Cl
  • InChi: 1S/C18H14ClNO4/c1-23-15(21)10-24-17-13-8-7-12(19)9-14(13)20-18(22)16(17)11-5-3-2-4-6-11/h2-9H,10H2,1H3,(H,20,22)
  • InChiKey: ABVJPTKPDXVKOP-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-[(7-chloro-2-oxo-3-phenyl-1H-quinolin-4-yl)oxy]acetic acid methyl ester
  • methyl 2-[(7-chloro-2-oxo-3-phenyl-1H-quinolin-4-yl)oxy]ethanoate
  • 2-[(7-chloro-2-keto-3-phenyl-1H-quinolin-4-yl)oxy]acetic acid methyl ester

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Rattus norvegicus Glutamate (NMDA) receptor subunit zeta 1 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis nmda type glutamate receptor Get druggable targets OG5_133478 All targets in OG5_133478
Schistosoma mansoni glutamate receptor NMDA Get druggable targets OG5_133478 All targets in OG5_133478
Echinococcus granulosus nmda type glutamate receptor Get druggable targets OG5_133478 All targets in OG5_133478
Schistosoma japonicum Glutamate [NMDA] receptor subunit zeta-1 precursor, putative Get druggable targets OG5_133478 All targets in OG5_133478
Schistosoma japonicum Glutamate [NMDA] receptor subunit zeta-1 precursor, putative Get druggable targets OG5_133478 All targets in OG5_133478
Echinococcus multilocularis glutamate receptor NMDA Get druggable targets OG5_133478 All targets in OG5_133478
Echinococcus granulosus nmda type glutamate receptor Get druggable targets OG5_133478 All targets in OG5_133478
Schistosoma japonicum expressed protein Get druggable targets OG5_133478 All targets in OG5_133478
Echinococcus multilocularis nmda type glutamate receptor Get druggable targets OG5_133478 All targets in OG5_133478
Schistosoma japonicum Glutamate [NMDA] receptor subunit zeta-1 precursor, putative Get druggable targets OG5_133478 All targets in OG5_133478
Echinococcus granulosus glutamate receptor NMDA Get druggable targets OG5_133478 All targets in OG5_133478

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Drosophila melanogaster Glutamate receptor IA Glutamate (NMDA) receptor subunit zeta 1   938 aa 979 aa 23.7 %
Drosophila melanogaster NMDA receptor 2 Glutamate (NMDA) receptor subunit zeta 1   938 aa 878 aa 27.4 %
Echinococcus multilocularis glutamate (NMDA) receptor subunit Glutamate (NMDA) receptor subunit zeta 1   938 aa 822 aa 23.2 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis bromodomain adjacent to zinc finger domain 0.0037 0.0648 0.1554
Echinococcus multilocularis glutamate receptor NMDA 0.0095 0.2927 0.702
Toxoplasma gondii thioredoxin reductase 0.0087 0.2597 1
Echinococcus granulosus thioredoxin glutathione reductase 0.0087 0.2617 0.6277
Loa Loa (eye worm) hypothetical protein 0.0039 0.0745 0.2751
Echinococcus granulosus bromodomain adjacent to zinc finger domain 0.0037 0.0648 0.1554
Leishmania major aldehyde dehydrogenase, mitochondrial precursor 0.0062 0.163 0.5614
Brugia malayi Thioredoxin reductase 0.0087 0.2597 1
Echinococcus multilocularis nmda type glutamate receptor 0.0127 0.4169 1
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.003 0.0393 0.5
Schistosoma mansoni hypothetical protein 0.0037 0.065 0.065
Mycobacterium tuberculosis Probable aldehyde dehydrogenase 0.0062 0.163 0.1975
Loa Loa (eye worm) hypothetical protein 0.0043 0.0914 0.3414
Entamoeba histolytica hypothetical protein 0.0037 0.065 0.5
Schistosoma mansoni hypothetical protein 0.0021 0.0042 0.0042
Echinococcus granulosus dihydrolipoamide dehydrogenase 0.003 0.0393 0.0943
Mycobacterium tuberculosis Probable membrane NADH dehydrogenase NdhA 0.0198 0.6918 0.8879
Loa Loa (eye worm) glutathione reductase 0.0087 0.2597 1
Brugia malayi dihydrolipoyl dehydrogenase, mitochondrial precursor, putative 0.003 0.0393 0.1234
Echinococcus granulosus nmda type glutamate receptor 0.01 0.3106 0.7449
Echinococcus granulosus aldehyde dehydrogenase mitochondrial 0.0062 0.163 0.391
Brugia malayi Bromodomain containing protein 0.0076 0.2196 0.8406
Schistosoma mansoni bromodomain containing protein 0.0064 0.1732 0.1732
Brugia malayi hypothetical protein 0.0037 0.065 0.2256
Plasmodium vivax thioredoxin reductase, putative 0.0087 0.2597 1
Schistosoma mansoni acetyl-CoA C-acetyltransferase 0.0023 0.0118 0.0118
Echinococcus granulosus nmda type glutamate receptor 0.0127 0.4169 1
Giardia lamblia NADH oxidase lateral transfer candidate 0.003 0.0393 0.5
Plasmodium falciparum glutathione reductase 0.0087 0.2597 1
Brugia malayi glutathione reductase 0.0087 0.2597 1
Schistosoma mansoni dihydrolipoamide dehydrogenase 0.003 0.0393 0.0393
Loa Loa (eye worm) hypothetical protein 0.0042 0.0839 0.3118
Loa Loa (eye worm) thioredoxin reductase 0.0087 0.2597 1
Trichomonas vaginalis mercuric reductase, putative 0.003 0.0393 0.5
Brugia malayi PHD-finger family protein 0.0025 0.0211 0.0512
Schistosoma mansoni glutamate receptor NMDA 0.0109 0.3454 0.3454
Mycobacterium ulcerans aldehyde dehydrogenase 0.0062 0.163 1
Entamoeba histolytica hypothetical protein 0.0037 0.065 0.5
Echinococcus multilocularis aldehyde dehydrogenase, mitochondrial 0.0062 0.163 0.391
Toxoplasma gondii aldehyde dehydrogenase 0.0062 0.163 0.5614
Echinococcus multilocularis dihydrolipoamide dehydrogenase 0.003 0.0393 0.0943
Trichomonas vaginalis glutathione reductase, putative 0.003 0.0393 0.5
Mycobacterium tuberculosis Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot 0.003 0.0393 0.0359
Chlamydia trachomatis dihydrolipoyl dehydrogenase 0.003 0.0393 1
Brugia malayi Bromodomain containing protein 0.0039 0.0742 0.2622
Echinococcus multilocularis thioredoxin glutathione reductase 0.0087 0.2617 0.6277
Echinococcus granulosus bromodomain adjacent to zinc finger domain 0.0061 0.159 0.3814
Mycobacterium ulcerans dihydrolipoamide dehydrogenase, LpdB 0.003 0.0393 0.1818
Echinococcus granulosus fetal alzheimer antigen falz 0.0023 0.0118 0.0282
Schistosoma mansoni aldehyde dehydrogenase 0.0062 0.163 0.163
Echinococcus granulosus glutamate receptor NMDA 0.0095 0.2927 0.702
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0037 0.065 0.1559
Wolbachia endosymbiont of Brugia malayi dihydrolipoamide dehydrogenase E3 component 0.003 0.0393 0.5
Echinococcus multilocularis bromodomain adjacent to zinc finger domain 0.0061 0.159 0.3814
Treponema pallidum NADH oxidase 0.003 0.0393 1
Mycobacterium ulcerans flavoprotein disulfide reductase 0.003 0.0393 0.1818
Mycobacterium tuberculosis Probable reductase 0.0198 0.6918 0.8879
Mycobacterium ulcerans aldehyde dehydrogenase 0.0062 0.163 1
Mycobacterium tuberculosis NADPH-dependent mycothiol reductase Mtr 0.0087 0.2597 0.3237
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0037 0.065 0.1559
Entamoeba histolytica hypothetical protein 0.0037 0.065 0.5
Echinococcus multilocularis fetal alzheimer antigen, falz 0.0023 0.0118 0.0282
Trypanosoma brucei trypanothione reductase 0.0087 0.2597 1
Mycobacterium leprae DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE 0.022 0.7776 1
Mycobacterium tuberculosis Probable dehydrogenase 0.0198 0.6918 0.8879
Leishmania major trypanothione reductase 0.0087 0.2597 1
Mycobacterium tuberculosis NAD(P)H quinone reductase LpdA 0.022 0.7776 1
Mycobacterium ulcerans dihydrolipoamide dehydrogenase 0.003 0.0393 0.1818
Schistosoma mansoni transcription factor LCR-F1 0.0037 0.065 0.065
Loa Loa (eye worm) hypothetical protein 0.0072 0.2027 0.7768
Plasmodium vivax glutathione reductase, putative 0.0087 0.2597 1
Echinococcus multilocularis Glutamate receptor, ionotropic kainate 3 0.0032 0.0467 0.1119
Echinococcus multilocularis nmda type glutamate receptor 0.01 0.3106 0.7449
Mycobacterium tuberculosis Probable NADH dehydrogenase Ndh 0.0198 0.6918 0.8879
Plasmodium falciparum thioredoxin reductase 0.0087 0.2597 1
Entamoeba histolytica hypothetical protein 0.0037 0.065 0.5
Mycobacterium ulcerans aldehyde dehydrogenase 0.0062 0.163 1
Trypanosoma cruzi trypanothione reductase, putative 0.0087 0.2597 1
Schistosoma mansoni aldehyde dehydrogenase 0.0062 0.163 0.163
Mycobacterium tuberculosis Putative ferredoxin reductase 0.0198 0.6918 0.8879
Mycobacterium tuberculosis Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB 0.0198 0.6918 0.8879
Mycobacterium tuberculosis Probable oxidoreductase 0.022 0.7776 1
Mycobacterium tuberculosis Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras 0.022 0.7776 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 3.2 uM In vitro ability to displace [3H]L-689,560 binding to glycine site on the N-methyl-D-aspartate (NMDA) glutamate receptor 1 from rat cortical membranes ChEMBL. 9057862
IC50 (binding) = 3.2 uM In vitro ability to displace [3H]L-689,560 binding to glycine site on the N-methyl-D-aspartate (NMDA) glutamate receptor 1 from rat cortical membranes ChEMBL. 9057862
Kb (functional) = 0.96 uM Evaluated to antagonize NMDA responses in a rat cortical slice preparations ChEMBL. 9057862
Kb (functional) = 0.96 uM Evaluated to antagonize NMDA responses in a rat cortical slice preparations ChEMBL. 9057862
No. of mice protected (functional) = 1 compound was evaluated in vivo for their ability to protect against audiogenic seizure in DBA/2 mice when administered 100 mg/kg ip 30 min prior to noise stimulation out of 8 mice tested ChEMBL. 9057862
No. of mice protected (functional) = 1 compound was evaluated in vivo for their ability to protect against audiogenic seizure in DBA/2 mice when administered 100 mg/kg ip 30 min prior to noise stimulation out of 8 mice tested ChEMBL. 9057862

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.